1 active not recruiting, 1 recruiting, 1 withdrawn. 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Active not recruiting 1 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Endometrium Tumor: new trials by email Literature Review of Endometrium Tumor trials Research Report on Endometrium Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer Vic-trastuzumab duocarmazine (SYD985) + paclitaxel - HER2-positive Breast Cancer, HER2 Low | Phase 1 | Withdrawn | QuantumLeap Healthcare Collaborative | 2021-07-28 | 2023-11-18 | |
| Radiomics and Molecular Classification in Endometrial Cancer Radiomics - Endometrial Cancer, Uterine Cancer | Not applicable | Active not recruiting | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 250 | 2021-01-15 | 2025-05-09 |
| The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study. Sentinel lymph node (SLN) biosy +/- lymphadenectomy - Endometrial Cancer, Cervical Cancer | Recruiting | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 500 | 2020-01-02 | 2022-08-17 |
Endometrial Neoplasms (3) · Breast Neoplasms (1) · Lymphatic Metastasis (1) · Neoplasm Metastasis (1) · Neoplasm Micrometastasis (1) · Ovarian Neoplasms (1) · Triple Negative Breast Neoplasms (1) · Urinary Bladder Neoplasms (1) · Uterine Cervical Neoplasms (1) · Uterine Neoplasms (1)
Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Genital Diseases (3) · Genital Diseases, Female (3) · Genital Neoplasms, Female (3) · Neoplasms (3) · Neoplasms by Site (3) · Urogenital Diseases (3) · Urogenital Neoplasms (3) · Uterine Diseases (3) · Neoplastic Processes (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Uterine Neoplasms (2) · Adnexal Diseases (1)
Paclitaxel (1) · Radiomics (1) · sarcolipin (1) · trastuzumab duocarmazine (1)
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (2) · QuantumLeap Healthcare Collaborative (1)
Italy (2) · United States (1)
Anthony Elias, MD (1) · Fabio Martinelli, MD (1) · Paula R Pohlmann, MD, MSc, PhD (1)
PMID 22120175, PMID 28577885, PMID 30286945, PMID 30318103, PMID 30353577, PMID 30833435, PMID 31345606, PMID 31450214, PMID 31818860, PMID 31863354, PMID 31871114